Quanticate announces plans to accelerate growth in North America

Lifeasible Released a Platform Based on High-throughput Plant Phenotyping

COFEPRIS Certifies 5 CTL Amedica Devices for Commercialization, Marketing in Mexico

CTL Amedica Corporation has received official certification from COFEPRIS, the agency charged with overseeing the quality of medical devices and products made in and imported into Mexico, to commercialize and market the Valeo II silicon nitride interbody product line in Mexico. The Valeo II interbody devices are made entirely of silicon nitride, which demonstrates a superior osteogenic response for enhanced fusion, promotes unique anti-bacterial properties and provides comprehensive imaging across all modalities. CTL Amedica is the world’s exclusive provider of silicon nitride spine products, and the certification includes 5 silicon nitride devices.

Matexcel Enlarged Its Offerings for Co-based Metal Powder Products

Creative BioMart Provides MHC Solutions for Cell Therapy & Vaccine Development

Profacgen Updated Its In Silico Protein-protein Interactions Prediction Service

RCH Solutions To Present at 20/15 Visioneers’ Virtual Cloud Lab, HTE and Lab Automation Conference

Leading a talk on Next Generation Compute Environments, the long-time provider of computing consulting and execution services exclusively to R&D teams in the Life Sciences will take the virtual stage on November 8, 2022.

Full-Scale PROTAC In Vivo Evaluation Services to Facilitate PROTAC Drug R&D

BOC Sciences can take care of the PROTAC in vivo evaluation workload for clients with a transparent project process and comprehensive evaluation reports to facilitate PROTAC discovery and development programs prior to clinical trials.

Synthetic Biology Platform: Meet All Synthetic Biology Demands in One Place

The Synthetic Biology Platform is designed to program comprehensive biosynthesis development in one place.

New tool to identify patients at high risk of Kidney Dysfunction presented at American Society of Nephrology Conference

A new tool has been developed to identify those diabetes patients who are at risk of developing Chronic Kidney Disease. Early diagnosis can lead to earlier treatment and save lives.

CD ComputaBio Introduces Four Docking Software for Drug Development

Pronalyse Supports Drug Discovery with the Launch of Biosimilar Analysis Solutions

Creative Proteomics Boosts Your Project with Unknown Metabolite Identification Services

Creative Proteomics Cytokine Announces the Launch of Chemokine Detection Service

Vermont Initiative Gives Clinicians New Tools for Infectious Disease Diagnosis and Response

I wanted to share the Vermont Department of Health and VisualDx just launched the Clinician Support Initiative to help healthcare professionals respond to emergent infectious disease outbreaks, like Monkeypox, Covid, and Polio, by leveraging assistive technology. Given the challenge of identifying and treating rare diseases amid ongoing staffing and burnout issues, Vermont is offering all clinicians in the state free access to VisualDx’s diagnostic support platform. The tool contains clinical information, medical reference images, and real-time reporting, all of which are critical for patient care and public health response.

medmix Drug Delivery (Haselmeier™) and AARDEX® Group Join Forces to Improve Self-Administration of Injectable Drugs in Clinical Trials

medmix Drug Delivery (Haselmeier™) and AARDEX® Group Join Forces to Improve Self-Administration of Injectable Drugs in Clinical Trials. Liege, Belgium - November 3, 2022: medmix Drug Delivery (Haselmeier) and AARDEX Group announced today a collaboration, combining Haselmeier´s D-Flex™ Logbook with AARDEX Group’s Medication Adherence software and hardware ecosystem.

Jumo Health Honored in Inc.’s Inaugural Power Partner Awards

Jumo Health, a global provider of age appropriate, culturally sensitive medical education resources, today announced it has been recognized by Inc. Magazine in its inaugural Power Partner Awards.

Mayo Clinic, Orbita to Speak on Successful Utilization of Intelligent Virtual Assistants at HCIC

Vaxess Announces $27M in Series B Funding

Vaxess Technologies, Inc., a life sciences company developing a shelf-stable, sustained-release vaccine patch, today announced the closing of its Series B funding.

Creative Enzymes Launches Raw Materials for Manufacturing Diagnostic Kits